News | Artificial Intelligence | August 17, 2020

Subtle's AI improves MRI safety exams by reducing gadolinium dose

Subtle's AI improves MRI safety exams by reducing gadolinium dose

August 17, 2020 — Subtle Medical is approved for Phase II of its NIH SBIR grant to develop an innovative artificial intelligence (AI)-powered software, SubtleGAD, which uses deep learning (DL) to reduce gadolinium dosage needed during magnetic resonance imaging (MRI) exams. Phase II funding is based on the results achieved during Phase I, as well as the scientific and technical merit of the project.

SubtleGAD will benefit millions of patients with advanced chronic kidney disease (CKD) who cannot currently undergo contrast-enhanced MRI, and will reduce the risk of gadolinium retention for many more patients with normal kidney function.

Recognizing the impact of Subtle Medical's AI software on improving patient safety and experience in medical imaging, Subtle Medical was named to 2020 CB Insights Digital Health 150.  Subtle was previously named CB Insights Top AI 100. 

"Receiving Phase II of the SBIR grant is a tremendous nod to our progress with SubtleGAD. With this technology, hospitals and imaging centers will be able to deliver safer low-dose contrast-enhanced MRI exams without sacrificing the clinical quality of the images," said Enhao Gong, PhD, Co-founder and CEO. "We appreciate the NIH's support in the development of this novel AI product and look forward to deploying it in clinical settings."

Gadolinium-based contrast agents (GBCAs) are used in approximately one-third of the 40 million MRI scans performed annually. The usage of GBCAs has been linked to the development of nephrogenic systemic fibrosis (NSF), and the recent identification of gadolinium deposition within the brain and body has raised safety concerns about the usage of GBCAs. The FDA has issued warnings about gadolinium retention and required GBCA manufacturers to further assess the safety issues.

Subtle Medical presented SubtleGAD research at RSNA 2018, NeurIPS 2019, and ISMRM 2020, demonstrating positive results from clinical reader studies conducted in multiple institutes in the US and abroad.

SubtleGAD is the third product under development in Subtle Medical's growing portfolio of AI technologies aimed at improving the quality and efficiency of radiology. SubtleMR applies two methods of image enhancement — denoising and increasing image sharpness — to improve image quality, while SubtlePET denoises scans that were conducted in 25% of the original scan duration. Both products are FDA-cleared and CE-marked to run on all scanner models and are in clinical use in the US and abroad.

For more information: www.subtlemedical.com

Related Content of MRI Gadolinium Safety Concerns

The Debate Over Gadolinium MRI Contrast Toxicity

VIDEO: How Serious is MRI Gadolinium Retention in the Brain and Body? An interview with Max Wintermark, M.D.

VIDEO “Big Concerns Remain for MRI Gadolinium Contrast Safety at RSNA 2017,” An interview with Emanuel Kanal, M.D.

Radiology Has Failed to Properly Assess or Track MRI Gadolinium Contrast Safety

Recent Developments in Contrast Media

FDA Committee Votes to Expand Warning Labels on Gadolinium-Based Contrast Agents

European Medicines Agency Issues Update on Gadolinium Contrast Agents

ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents

FDA: No Harm in MRI Gadolinium Retention in the Brain

VIDEO: MRI Gadolinium Contrast Retention in the Brain

Gadolinium May Remain in Brain After Contrast MRI


Related Content

News | Imaging Software Development

June 05, 2025 — Nano-X Imaging Ltd. has announced that its deep-learning medical imaging analytics subsidiary, Nanox AI ...

Time June 05, 2025
arrow
News | Prostate Cancer

June 5, 2025 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time June 05, 2025
arrow
News | Ultrasound Imaging

June 3, 2025 — In a collaborative study between the Departments of Radiology at the Children’s Hospital of Philadelphia ...

Time June 04, 2025
arrow
News | Breast Imaging

June 2, 2025 — Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S ...

Time June 02, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

Hyperfine, Inc., producer of the world’s first FDA-cleared AI-powered portable MRI system for the brain — the Swoop ...

Time May 29, 2025
arrow
News | Imaging Software Development

May 27, 2025 — DeepLook Medical, a company advancing medical imaging through visual enhancement technology, recently ...

Time May 28, 2025
arrow
News | Imaging Software Development

May 20, 2025 – Intelerad, a provider of medical imaging software solutions, recently announced its prime partnership ...

Time May 21, 2025
arrow
News | Teleradiology

May 21, 2025 — Konica Minolta Healthcare Americas, Inc and NewVue have announced the introduction of Exa Teleradiology ...

Time May 21, 2025
arrow
News | Breast Imaging

May 13, 2025 — In one of the larger studies of its kind, researchers have identified six breast texture patterns that ...

Time May 16, 2025
arrow
News | Computed Tomography (CT)

May 15, 2025 — GE HealthCare has launched CleaRecon DL, technology powered by a deep-learning algorithm, to improve the ...

Time May 15, 2025
arrow
Subscribe Now